Fig. 1From: Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancera Schematic illustration of the stepwise construction of DSF@HCu nanomedicine, and (b) NIR photothermal-augmented and in-situ Cu2+ release-activated DSF chemotherapy for the efficient killing of cancer cells and suppression of tumor growth with minimized side effectsBack to article page